The annual American Society of Clinical Oncology conference occurred in Chicago, with France 24 reporting a new pancreatic cancer pill that doubles survival time and major announcements on breast, bladder, and neck cancers. All claims originate from the same left-center source. Analyses from progressive, conservative, libertarian, and devil's advocate perspectives differ on implications for funding, regulation, and data reliability.